Stock Price Quote

BAJAJ HEALTHCARE LTD.

NSE : BAJAJHCAREBSE : 539872ISIN CODE : INE411U01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE314.70-6.2 (-1.93 %)
PREV CLOSE ( ) 320.90
OPEN PRICE ( ) 322.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11458
TODAY'S LOW / HIGH ( )313.10 322.00
52 WK LOW / HIGH ( )245.05 511
NSE314.50-6.05 (-1.89 %)
PREV CLOSE( ) 320.55
OPEN PRICE ( ) 315.00
BID PRICE (QTY) 314.50 (96)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 89515
TODAY'S LOW / HIGH( ) 313.00 321.35
52 WK LOW / HIGH ( )275.7 513.4
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-07 1993
Management Info
Sajankumar Rameshwarlal Bajaj - Chairman Sajankumar Rameshwarlal Bajaj - Managing Director
Registered Office

Address 602-606, Bhoomi Velocity Infotech Park,Plot No. B-39, B-39/ A, B-39 A/1, Road No. 23,Wagle Industrial Estate, Thane (West),
Thane Dist,
Maharashtra-401604

Phone 022 6617400 / 401

Email bajajhealth@bajajhealth.com / investors@bajajhealth.com

Website www.bajajhealth.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,L B S Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

15Apr Clarification W.R.T. Increase In Volu
Company''s reply to the Exchange''s clarification w.r.t. increase in vol..
15Apr Bajaj Healthcare informs about clarifi
Bajaj Healthcare has informed that, they have been regularly informing a..
28Mar Bajaj Healthcare informs about trading
Bajaj Healthcare has informed that the 'Trading Window' for dealing in t..
28Feb Bajaj Healthcare enters into definitiv
Bajaj Healthcare (BHL) has entered into a definitive CDMO agreement with..
28Feb Bajaj Healthcare zooms on entering int
Bajaj Healthcare is currently trading at Rs. 365.55, up by 45.15 points..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit-21.9600000000001430.25
Gross Profit 63.2499999999999 582.17
Operating Profit 203.331084.44
Net Sales 1085.736732.92

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE)
peergroup  1455.20 (10.00%)
M.Cap ( in Cr)846.88
Solara Active Pharma (BSE)
peergroup  551.45 (16.32%)
M.Cap ( in Cr)1985.01
Abbott India (BSE)
peergroup  26131.85 (0.29%)
M.Cap ( in Cr)55528.36
Windlas Biotech (BSE)
peergroup  555.05 (6.97%)
M.Cap ( in Cr)1154.42
Concord Biotech (BSE)
peergroup  1595.25 (1.05%)
M.Cap ( in Cr)16688.90

Shareholding Pattern

PROMOTERS 67.73%
NON-INSTITUTION 31.3%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Bajaj Healthcare Ltd.

Bajaj Healthcare Ltd. was incorporated in the year 1993. Its today's share price is 314.7. Its current market capitalisation stands at Rs 868.52 Cr. In the latest quarter, company has reported Gross Sales of Rs. 6732.92 Cr and Total Income of Rs.6748.9 Cr. The company's management includes Apurva Bandivadekar, Kejal Shah, Loukik Tipnis, Ram B Banarse, Hemant R Karnik, Pakshal A Jain, Dhananjay S Hatle, Namrata Sajankumar Bajaj, Anil Jain, Sajankumar Rameshwarlal Bajaj, Sajankumar Rameshwarlal Bajaj.

It is listed on the BSE with a BSE Code of 539872 , NSE with an NSE Symbol of BAJAJHCARE and ISIN of INE411U01027. It's Registered office is at 602-606, Bhoomi Velocity Infotech Park,Plot No. B-39, B-39/ A, B-39 A/1, Road No. 23,Wagle Industrial Estate, Thane (West)Thane Dist-401604, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Chaturvedi & Agrawal, Paresh Rakesh & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.